Results 271 to 280 of about 60,673,388 (296)
Some of the next articles are maybe not open access.

CLINICAL STUDIES WITH CURCUMIN

2007
Curcumin has long been expected to be a therapeutic or preventive agent for several major human diseases because of its antioxidative, anti-inflammatory, and anticancerous effects. In phase I clinical studies, curcumin with doses up to 3600-8000 mg daily for 4 months did not result in discernible toxicities except mild nausea and diarrhea.
Chih-Hung, Hsu, Ann-Lii, Cheng
openaire   +2 more sources

Arson: A Clinical Study

The Canadian Journal of Psychiatry, 1982
Psychiatric, psychosocial and medicolegal issues related to 34 arsonists and 50 controls are described. Arson was most frequently committed by males who suffered from personality disorder, mental retardation or depressive neurosis. Poor school and work records also characterized their background when compared to the control forensic psychiatric ...
openaire   +2 more sources

Retrospective clinical studies

Journal of Pediatric Urology, 2016
Patient-based retrospective studies are most often based on one unique patient cohort from one particular institution. At best, they can give rise to observations leading to future prospective studies and new hypotheses. The study by Pamela Ellsworth et al.
openaire   +2 more sources

Clinical Studies on Osteoporosis

1990
Osteoporosis is, by definition, a reduction in bone mass with remaining bone of normal composition. The related loss in bone strength results in fractures with little or no abnormal force. Since a valid measurement of low bone mass or osteopenia was not widely available until recently, the diagnosis of osteoporosis was based on evidence of vertebral ...
J. E. Harrison   +11 more
openaire   +2 more sources

Logistic Regression in Clinical Studies.

International Journal of Radiation Oncology, Biology, Physics, 2021
E. Zabor   +3 more
semanticscholar   +1 more source

Clinical studies of topiramate

Drugs of Today, 1999
Topiramate had well-documented efficacy as an adjunctive agent for partial-onset seizures in 5 double-blind, parallel trials, reducing seizure frequency by 35-47% at 400 mg/day, the optimal dose for most patients. It can also be used as monotherapy for partial-onset seizures. A broad spectrum of action is suggested by studies showing efficacy against a
openaire   +2 more sources

Zolmitriptan clinical studies

Drugs of Today, 1998
Zolmitriptan, a selective 5-HT(1B/D) agonist was developed for the acute treatment of migraine. Dose-finding studies show a clearly defined dose response curve for the oral formulation with onset of efficacy demonstrated within 45 min of dosing. Clinical trials support its efficacy in all types of migraine, with excellent safety and tolerability in ...
openaire   +2 more sources

A CLINICAL STUDY OF HYDRAMNIOS

Obstetrical & Gynecological Survey, 1960
J C, BUCKINGHAM   +3 more
openaire   +2 more sources

CLINICAL STUDIES ON TERRAMYCIN

Annals of the New York Academy of Sciences, 1950
M, FINLAND   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy